Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- KINGS COLLEGE LONDON
- University of Oxford;
- King's College London
- AALTO UNIVERSITY
- Heriot Watt University
- The University of Edinburgh;
- UNIVERSITY OF VIENNA
- University of Cambridge;
- University of Liverpool
- University of London
- ;
- Atlantic Technological University;
- City University London
- Nature Careers
- Royal Horticultural Society;
- University of Cambridge
- University of Dundee;
- University of Liverpool;
- 9 more »
- « less
-
Field
-
coagulation to extracellular matrix (ECM) homeostasis. Most serpins are inhibitory, and use a covalent mode of inhibition to inhibit their target serine proteinases (1). We and others have suggested serpins
-
to join the Antigen Discovery Group at the University of Dundee. This CRUK-funded project focuses on identifying targetable T cell antigens in early-stage mesothelioma, with the goal of developing a novel
-
plans (and ongoing review) to ensure that targets are met according to study timelines. Supervision would be provided by senior Centre staff, including Professor Cathy Creswell. About You You will have or
-
mechanisms that can lead to the development of novel therapeutic targets. The individual will report to the PI of the headache Group, Dr Philip R Holland and will be responsible for conducting their own
-
world-leading researchers from Oxford, Harvard, and other premier institutions to develop innovative gene-silencing and gene-editing technologies targeting the underlying causes of genetic heart diseases
-
gene-silencing and gene-editing technologies targeting the underlying causes of genetic heart diseases. The successful candidate will work closely with chemists, molecular biologists, and clinicians
-
to investigate host-pathogen interactions for identification of novel targets for drug discovery. The main objective of this post is to conduct research on human pathogens using microbiology and molecular biology
-
to the development and implementation of strategies/action plans (and ongoing review) to ensure that targets are met according to study timelines. Supervision would be provided by senior Centre staff, including
-
primary headache disorders and related co-morbid conditions to help uncover novel disease mechanisms that can lead to the development of novel therapeutic targets. The individual will report to the PI
-
well as localization of targets or signal sources in passive-sensing settings. This is central to future 6G wireless communications applications, where radio-frequency sensing and data transfer (ISAC) are integrated